Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 8/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | LGALS3 | P17931 | 6/20 | 0.39 |
| ▸ | LGALS4 | P56470 | 4/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.35 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.35 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.35 |
| ▸ | FGF1 | P05230 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6129339 | 0.86 | LGALS8 (0.52) | LGALS8ALDH1A1THRBLGALS3LGALS4 | |
| SCHEMBL16869486 | 0.77 | DPP4 (0.36) | — | |
| SCHEMBL10972064 | 0.76 | LGALS3 (0.46) | LGALS8LGALS3LGALS4 | |
| SCHEMBL17283396 | 0.76 | LGALS8 (0.58) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL701054 | 0.74 | LGALS8 (0.56) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL5024268 | 0.74 | DPP4 (0.40) | — | |
| SCHEMBL1674815 | 0.74 | LGALS8 (0.56) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL2710870 | 0.73 | MAPK1 (0.41) | LGALS8ALDH1A1THRBLGALS3LGALS9 | |
| SCHEMBL16327733 | 0.71 | LGALS8 (0.60) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL10781121 | 0.70 | LGALS8 (0.57) | LGALS8LGALS3FGF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170143022-A1 | Compositions Incorporating an Umami Flavor Agent | SENOMYX INC (US) | 2017-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170143022-A1 | Compositions Incorporating an Umami Flavor Agent | TAS2R8, TAS2R45, TAS2R40 | LGALS8 580/4885ALDH1A1 263/4885THRB 2627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.